Physician profile
Jesse Thomas Beard
NPI 1598140014
$17,430.02
in general payments reported to CMS, 2019-2025
21 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $4,047 · 2021: $5,385 · 2022: $5,506 · 2023: $795 · 2024: $941 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,912 · Education: $99.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,912.48 |
| Education | $99.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,178.00 | 2020-2021 | |
| Elite Orthopedics, LLC | $4,191.42 | 2021-2025 | |
| Stryker Corporation | $3,725.15 | 2019-2025 | Mako, Insignia, Triathlon |
| Zimmer Biomet Holdings, INC. | $2,098.67 | 2019-2025 | Mymobility Platform, Oss Orthopedic Salvage System, Persona |
| Supreme Orthopedic Systems, LLC | $1,215.97 | 2021 | |
| Depuy Synthes Sales INC. | $232.86 | 2019-2024 | Na |
| Medacta USA, INC. | $131.74 | 2022-2025 | Gmk Sphere |
| Pacira Pharmaceuticals Incorporated | $109.03 | 2023-2025 | Zilretta, Exparel, Iovera |
| Amgen INC. | $94.22 | 2022-2024 | Evenity, Prolia |
| Fx Shoulder Solutions, INC | $85.41 | 2023-2025 | |
| Acera Surgical, INC. | $84.07 | 2025 | Restrata Wound Matrix |
| Boston Scientific Corporation | $70.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $55.33 | 2022-2023 | Seglentis |
| Pacira Therapeutics, INC. | $24.05 | 2021 | |
| Heraeus Medical, LLC. | $23.35 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.69 | 2024 | Strensiq |
| Heron Therapeutics, INC. | $21.92 | 2023 | Zynrelef |
| Abbott Laboratories | $21.53 | 2022 | |
| Medtronic, INC. | $18.85 | 2022 | |
| Medtronic USA, INC. | $14.05 | 2019 | |
| Vericel Corporation | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Beard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.